Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPG Block for Post-Dural Puncture Headache
NCT03560349Phase 2Withdrawn
- Sponsor
- University of Utah
- Start
- Jul 2018
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lidocaine 10% oropharyngeal spray in post-dural puncture headache (PDPH), sponsored by University of Utah. Planned start Jul 2018; status: withdrawn.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on NCT03560349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03560349.